content_top
34 companies, 1 interpreter! Insight, foresight
and recommendation
and recommendation
Cesca Therapeutics, Inc (KOOL)
0.00
(0.00%)
content_middle
Cesca is a leading regenerative medicine company that develops, commercializes and markets a range of automated technologies for cell-based therapeutics.
Its device division, ThermoGenesis, provides a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology.
Cesca is also leveraging its proprietary AutoXpress® technology platform to develop an automated, functionally-closed CAR-TXpress platform that addresses cellular manufacturing needs in the immuno-oncology field.
Previous Close:
0.00
Open:
3.31
Bid:
3.35
Ask:
3.40
1yr Target Price:
2.00
Day's Range:
3.16 - 3.34
52wk Range:
0.00 - 0.00
Volume:
7977
Average Daily Volume:
92565
Market Capitalization:
0.00M
Trailing Annual Dividend Yield:
N/A
Shares Outstanding:
0.00M
content_right
- November 16, 2015 - 10:34am | Earnings Q3
- September 1, 2015 - 11:48am | Research Notes
- June 23, 2015 - 10:44am | IP & Patents
- June 16, 2015 - 6:48am | Research Notes
- June 15, 2015 - 9:08am | BOD & C-Suite Updates
- May 29, 2015 - 10:32am | Out and About
- May 13, 2015 - 8:35am | Regulatory
- May 4, 2015 - 7:38am | BOD & C-Suite Updates
- March 2, 2015 - 8:53am | Governance & Transparency
- February 23, 2015 - 8:37am | BOD & C-Suite Updates
- February 17, 2015 - 11:18am | Earnings
- February 11, 2015 - 7:44am | Regulatory
- January 12, 2015 - 11:08am | BOD & C-Suite Updates
- January 2, 2015 - 7:54am | Research Notes
- December 12, 2014 - 9:13am | Out and About
- December 5, 2014 - 9:19am | BOD & C-Suite Updates
- November 20, 2014 - 11:28am | Regulatory
- November 18, 2014 - 9:29am | BOD & C-Suite Updates
- November 14, 2014 - 1:58pm | Earnings
- November 14, 2014 - 10:56am | Earnings